Loading…

Experience with the ketogenic diet in premature neonates

The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia open 2023-03, Vol.8 (1), p.200-204
Main Authors: Phitsanuwong, Chalongchai, Kim, Jeong‐A, Schimpf, Stephanie, Nordli, Douglas R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3
cites cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3
container_end_page 204
container_issue 1
container_start_page 200
container_title Epilepsia open
container_volume 8
creator Phitsanuwong, Chalongchai
Kim, Jeong‐A
Schimpf, Stephanie
Nordli, Douglas R.
description The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (>90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.
doi_str_mv 10.1002/epi4.12673
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d</doaj_id><sourcerecordid>2781016420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EolXphR-AInFBSFs8seOPCxKqFlipEhzgbNnOZNdLNg6OQ-m_x9uUquXAyZbn8TOjeQl5CfQCKK3f4Rj4BdRCsifktOaSrnTN9NMH9xNyPk17SinoGkDQ5-SECaYVl80pUevfI6aAg8fqOuRdlXdY_cActzgEX7UBcxWGakx4sHlOWA0YB5txekGedbaf8PzuPCPfP66_XX5eXX35tLn8cLXyjQK2clqDby2nHbMtWK685gK8qBtQChrBkWmnADvwEhuBQrbWOkqVF84pi-yMbBZvG-3ejCkcbLox0QZz-xDT1tiUg-_RaPTle9txh5ZraZ0Dd2zUWOkVQltc7xfXOLsDth6HnGz_SPq4MoSd2cZfRmspJVdF8OZOkOLPGadsDmHy2Pe2rGWeTC2ZAs2VpAV9_Q-6j3MayqoKpYCC4PWRertQPsVpStjdDwPUHPM1x3zNbb4FfvVw_Hv0b5oFgAW4Dj3e_Edl1l83fJH-AYWTr4s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2781016420</pqid></control><display><type>article</type><title>Experience with the ketogenic diet in premature neonates</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</creator><creatorcontrib>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</creatorcontrib><description>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (&gt;90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</description><identifier>ISSN: 2470-9239</identifier><identifier>EISSN: 2470-9239</identifier><identifier>DOI: 10.1002/epi4.12673</identifier><identifier>PMID: 36398475</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Age groups ; Calories ; Cardiac arrhythmia ; Case reports ; Convulsions &amp; seizures ; Diet ; Diet, Ketogenic - adverse effects ; Electroencephalography ; Epilepsy ; Epilepsy - drug therapy ; Humans ; Hypoglycemia ; Infant ; Infant, Newborn ; ketogenic diet ; Ketone Bodies - therapeutic use ; Ketosis ; neonate ; newborn ; Nutrition research ; Patients ; premature ; preterm ; Short ; Short s ; Treatment Outcome ; Twins</subject><ispartof>Epilepsia open, 2023-03, Vol.8 (1), p.200-204</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.</rights><rights>2022 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</citedby><cites>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</cites><orcidid>0000-0002-1201-0586 ; 0000-0001-5499-3835</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2781016420/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2781016420?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36398475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phitsanuwong, Chalongchai</creatorcontrib><creatorcontrib>Kim, Jeong‐A</creatorcontrib><creatorcontrib>Schimpf, Stephanie</creatorcontrib><creatorcontrib>Nordli, Douglas R.</creatorcontrib><title>Experience with the ketogenic diet in premature neonates</title><title>Epilepsia open</title><addtitle>Epilepsia Open</addtitle><description>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (&gt;90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</description><subject>Age groups</subject><subject>Calories</subject><subject>Cardiac arrhythmia</subject><subject>Case reports</subject><subject>Convulsions &amp; seizures</subject><subject>Diet</subject><subject>Diet, Ketogenic - adverse effects</subject><subject>Electroencephalography</subject><subject>Epilepsy</subject><subject>Epilepsy - drug therapy</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>ketogenic diet</subject><subject>Ketone Bodies - therapeutic use</subject><subject>Ketosis</subject><subject>neonate</subject><subject>newborn</subject><subject>Nutrition research</subject><subject>Patients</subject><subject>premature</subject><subject>preterm</subject><subject>Short</subject><subject>Short s</subject><subject>Treatment Outcome</subject><subject>Twins</subject><issn>2470-9239</issn><issn>2470-9239</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1v1DAQhi0EolXphR-AInFBSFs8seOPCxKqFlipEhzgbNnOZNdLNg6OQ-m_x9uUquXAyZbn8TOjeQl5CfQCKK3f4Rj4BdRCsifktOaSrnTN9NMH9xNyPk17SinoGkDQ5-SECaYVl80pUevfI6aAg8fqOuRdlXdY_cActzgEX7UBcxWGakx4sHlOWA0YB5txekGedbaf8PzuPCPfP66_XX5eXX35tLn8cLXyjQK2clqDby2nHbMtWK685gK8qBtQChrBkWmnADvwEhuBQrbWOkqVF84pi-yMbBZvG-3ejCkcbLox0QZz-xDT1tiUg-_RaPTle9txh5ZraZ0Dd2zUWOkVQltc7xfXOLsDth6HnGz_SPq4MoSd2cZfRmspJVdF8OZOkOLPGadsDmHy2Pe2rGWeTC2ZAs2VpAV9_Q-6j3MayqoKpYCC4PWRertQPsVpStjdDwPUHPM1x3zNbb4FfvVw_Hv0b5oFgAW4Dj3e_Edl1l83fJH-AYWTr4s</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Phitsanuwong, Chalongchai</creator><creator>Kim, Jeong‐A</creator><creator>Schimpf, Stephanie</creator><creator>Nordli, Douglas R.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1201-0586</orcidid><orcidid>https://orcid.org/0000-0001-5499-3835</orcidid></search><sort><creationdate>202303</creationdate><title>Experience with the ketogenic diet in premature neonates</title><author>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age groups</topic><topic>Calories</topic><topic>Cardiac arrhythmia</topic><topic>Case reports</topic><topic>Convulsions &amp; seizures</topic><topic>Diet</topic><topic>Diet, Ketogenic - adverse effects</topic><topic>Electroencephalography</topic><topic>Epilepsy</topic><topic>Epilepsy - drug therapy</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>ketogenic diet</topic><topic>Ketone Bodies - therapeutic use</topic><topic>Ketosis</topic><topic>neonate</topic><topic>newborn</topic><topic>Nutrition research</topic><topic>Patients</topic><topic>premature</topic><topic>preterm</topic><topic>Short</topic><topic>Short s</topic><topic>Treatment Outcome</topic><topic>Twins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phitsanuwong, Chalongchai</creatorcontrib><creatorcontrib>Kim, Jeong‐A</creatorcontrib><creatorcontrib>Schimpf, Stephanie</creatorcontrib><creatorcontrib>Nordli, Douglas R.</creatorcontrib><collection>Wiley Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Epilepsia open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phitsanuwong, Chalongchai</au><au>Kim, Jeong‐A</au><au>Schimpf, Stephanie</au><au>Nordli, Douglas R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience with the ketogenic diet in premature neonates</atitle><jtitle>Epilepsia open</jtitle><addtitle>Epilepsia Open</addtitle><date>2023-03</date><risdate>2023</risdate><volume>8</volume><issue>1</issue><spage>200</spage><epage>204</epage><pages>200-204</pages><issn>2470-9239</issn><eissn>2470-9239</eissn><abstract>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (&gt;90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36398475</pmid><doi>10.1002/epi4.12673</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-1201-0586</orcidid><orcidid>https://orcid.org/0000-0001-5499-3835</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2470-9239
ispartof Epilepsia open, 2023-03, Vol.8 (1), p.200-204
issn 2470-9239
2470-9239
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d
source Open Access: PubMed Central; Publicly Available Content Database; Wiley Open Access
subjects Age groups
Calories
Cardiac arrhythmia
Case reports
Convulsions & seizures
Diet
Diet, Ketogenic - adverse effects
Electroencephalography
Epilepsy
Epilepsy - drug therapy
Humans
Hypoglycemia
Infant
Infant, Newborn
ketogenic diet
Ketone Bodies - therapeutic use
Ketosis
neonate
newborn
Nutrition research
Patients
premature
preterm
Short
Short s
Treatment Outcome
Twins
title Experience with the ketogenic diet in premature neonates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A58%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20with%20the%20ketogenic%20diet%20in%20premature%20neonates&rft.jtitle=Epilepsia%20open&rft.au=Phitsanuwong,%20Chalongchai&rft.date=2023-03&rft.volume=8&rft.issue=1&rft.spage=200&rft.epage=204&rft.pages=200-204&rft.issn=2470-9239&rft.eissn=2470-9239&rft_id=info:doi/10.1002/epi4.12673&rft_dat=%3Cproquest_doaj_%3E2781016420%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2781016420&rft_id=info:pmid/36398475&rfr_iscdi=true